Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
81.62B | 76.89B | 77.96B | 66.85B | 59.98B | 60.59B | Gross Profit |
15.23B | 15.46B | 14.89B | 13.21B | 12.90B | 13.07B | EBIT |
3.97B | 1.62B | 4.74B | 4.68B | 5.18B | 4.92B | EBITDA |
8.04B | 7.56B | 8.57B | 7.99B | 8.17B | 7.62B | Net Income Common Stockholders |
3.10B | 1.51B | 3.15B | 4.66B | 3.82B | 3.44B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
19.89B | 18.70B | 17.69B | 13.82B | 15.46B | 12.35B | Total Assets |
80.65B | 76.41B | 70.66B | 66.87B | 56.87B | 48.13B | Total Debt |
11.46B | 13.59B | 11.18B | 7.77B | 9.15B | 10.43B | Net Debt |
-8.43B | -5.11B | -6.51B | -6.04B | -6.31B | -1.92B | Total Liabilities |
27.45B | 26.03B | 23.43B | 22.54B | 20.67B | 21.61B | Stockholders Equity |
53.10B | 50.30B | 47.16B | 44.27B | 36.16B | 26.50B |
Cash Flow | Free Cash Flow | ||||
0.00 | 41.00M | 2.08B | -1.59B | 771.00M | 2.95B | Operating Cash Flow |
0.00 | 4.82B | 7.31B | 3.68B | 5.14B | 6.49B | Investing Cash Flow |
0.00 | -5.13B | -5.86B | -5.97B | -4.62B | -3.28B | Financing Cash Flow |
0.00 | -260.00M | 1.53B | 171.00M | 1.91B | 2.14B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $22.01T | 19.09 | 14.32% | 0.52% | 9.56% | 26.52% | |
73 Outperform | $6.10T | 27.41 | 11.70% | 0.82% | -5.48% | -11.96% | |
72 Outperform | $3.78T | 10.32 | 7.85% | 2.76% | -0.45% | -17.53% | |
66 Neutral | $766.46B | 47.12 | 2.10% | 2.64% | -6.57% | -76.15% | |
60 Neutral | $11.59B | 10.39 | -7.23% | 2.94% | 7.46% | -10.76% | |
60 Neutral | ¥28.09B | 12.61 | 3.98% | 9.14% | ― | ||
44 Neutral | ¥497.26B | 13.78 | ― | -5.57% | 38.15% |